SYNERGY PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7682a339-4a9f-44a4-a6e3-12c1f97944ab/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-222.2M | 2017-01-01 – 2017-12-31 | evidence 0001347613-18-000003 |
| FY 2016 | $-145.3M | 2016-01-01 – 2016-12-31 | evidence 0001347613-17-000003 |
| FY 2015 | $-99.8M | 2015-01-01 – 2015-12-31 | evidence 0001104659-16-100066 |
| FY 2014 | $-94.3M | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-020147 |
| FY 2013 | $-193.2M | 2005-11-15 – 2014-03-31 | evidence 0001104659-14-037706 |
| FY 2012 | $-132.1M | 2005-11-15 – 2013-03-31 | evidence 0001104659-13-039606 |
| FY 2011 | $-83.3M | 2005-11-15 – 2012-03-31 | evidence 0001104659-12-035825 |
| FY 2010 | $-16.1M | 2010-01-01 – 2010-12-31 | evidence 0001104659-13-021753 |
| FY 2009 | $-8.2M | 2009-01-01 – 2009-12-31 | evidence 0001104659-12-018656 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).